Global Neurogenetic Testing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neurogenetic Testing market size was valued at US$ 466.6 million in 2023. With growing demand in downstream market, the Neurogenetic Testing is forecast to a readjusted size of US$ 1043.8 million by 2030 with a CAGR of 12.2% during review period.
The research report highlights the growth potential of the global Neurogenetic Testing market. Neurogenetic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurogenetic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurogenetic Testing market.
Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
Global key players of neurogenetic testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, etc. The top five players hold a share over 28%. In terms of product type, Exome Sequencing is the largest segment, occupied for a share of 44%, and in terms of application, Hospitals has a share about 46 percent.
Key Features:
The report on Neurogenetic Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurogenetic Testing market. It may include historical data, market segmentation by Type (e.g., Exome Sequencing, Whole Genome Sequencing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurogenetic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurogenetic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurogenetic Testing industry. This include advancements in Neurogenetic Testing technology, Neurogenetic Testing new entrants, Neurogenetic Testing new investment, and other innovations that are shaping the future of Neurogenetic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurogenetic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Neurogenetic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurogenetic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurogenetic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurogenetic Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurogenetic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurogenetic Testing market.
Market Segmentation:
Neurogenetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neurogenetic Testing market size was valued at US$ 466.6 million in 2023. With growing demand in downstream market, the Neurogenetic Testing is forecast to a readjusted size of US$ 1043.8 million by 2030 with a CAGR of 12.2% during review period.
The research report highlights the growth potential of the global Neurogenetic Testing market. Neurogenetic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurogenetic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurogenetic Testing market.
Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
Global key players of neurogenetic testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, etc. The top five players hold a share over 28%. In terms of product type, Exome Sequencing is the largest segment, occupied for a share of 44%, and in terms of application, Hospitals has a share about 46 percent.
Key Features:
The report on Neurogenetic Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurogenetic Testing market. It may include historical data, market segmentation by Type (e.g., Exome Sequencing, Whole Genome Sequencing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurogenetic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurogenetic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurogenetic Testing industry. This include advancements in Neurogenetic Testing technology, Neurogenetic Testing new entrants, Neurogenetic Testing new investment, and other innovations that are shaping the future of Neurogenetic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurogenetic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Neurogenetic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurogenetic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurogenetic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurogenetic Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurogenetic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurogenetic Testing market.
Market Segmentation:
Neurogenetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Exome Sequencing
- Whole Genome Sequencing
- RNA Sequencing
- General DNA Testing
- Hospitals
- Specialty Clinics
- Research Institutes
- Diagnostics Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Quest Diagnostics
- Mayo Clinic
- GeneDx
- Illumina
- Labcorp
- Invitae
- MedGenome Labs
- Connecticut Children’s
- CENTOGENE
- Victorian Clinical Genetics Services
- PacBio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurogenetic Testing Market Size 2019-2030
2.1.2 Neurogenetic Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurogenetic Testing Segment by Type
2.2.1 Exome Sequencing
2.2.2 Whole Genome Sequencing
2.2.3 RNA Sequencing
2.2.4 General DNA Testing
2.3 Neurogenetic Testing Market Size by Type
2.3.1 Neurogenetic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurogenetic Testing Market Size Market Share by Type (2019-2024)
2.4 Neurogenetic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Research Institutes
2.4.4 Diagnostics Laboratories
2.5 Neurogenetic Testing Market Size by Application
2.5.1 Neurogenetic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurogenetic Testing Market Size Market Share by Application (2019-2024)
3 NEUROGENETIC TESTING MARKET SIZE BY PLAYER
3.1 Neurogenetic Testing Market Size Market Share by Players
3.1.1 Global Neurogenetic Testing Revenue by Players (2019-2024)
3.1.2 Global Neurogenetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Neurogenetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROGENETIC TESTING BY REGIONS
4.1 Neurogenetic Testing Market Size by Regions (2019-2024)
4.2 Americas Neurogenetic Testing Market Size Growth (2019-2024)
4.3 APAC Neurogenetic Testing Market Size Growth (2019-2024)
4.4 Europe Neurogenetic Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurogenetic Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurogenetic Testing Market Size by Country (2019-2024)
5.2 Americas Neurogenetic Testing Market Size by Type (2019-2024)
5.3 Americas Neurogenetic Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurogenetic Testing Market Size by Region (2019-2024)
6.2 APAC Neurogenetic Testing Market Size by Type (2019-2024)
6.3 APAC Neurogenetic Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurogenetic Testing by Country (2019-2024)
7.2 Europe Neurogenetic Testing Market Size by Type (2019-2024)
7.3 Europe Neurogenetic Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurogenetic Testing by Region (2019-2024)
8.2 Middle East & Africa Neurogenetic Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurogenetic Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROGENETIC TESTING MARKET FORECAST
10.1 Global Neurogenetic Testing Forecast by Regions (2025-2030)
10.1.1 Global Neurogenetic Testing Forecast by Regions (2025-2030)
10.1.2 Americas Neurogenetic Testing Forecast
10.1.3 APAC Neurogenetic Testing Forecast
10.1.4 Europe Neurogenetic Testing Forecast
10.1.5 Middle East & Africa Neurogenetic Testing Forecast
10.2 Americas Neurogenetic Testing Forecast by Country (2025-2030)
10.2.1 United States Neurogenetic Testing Market Forecast
10.2.2 Canada Neurogenetic Testing Market Forecast
10.2.3 Mexico Neurogenetic Testing Market Forecast
10.2.4 Brazil Neurogenetic Testing Market Forecast
10.3 APAC Neurogenetic Testing Forecast by Region (2025-2030)
10.3.1 China Neurogenetic Testing Market Forecast
10.3.2 Japan Neurogenetic Testing Market Forecast
10.3.3 Korea Neurogenetic Testing Market Forecast
10.3.4 Southeast Asia Neurogenetic Testing Market Forecast
10.3.5 India Neurogenetic Testing Market Forecast
10.3.6 Australia Neurogenetic Testing Market Forecast
10.4 Europe Neurogenetic Testing Forecast by Country (2025-2030)
10.4.1 Germany Neurogenetic Testing Market Forecast
10.4.2 France Neurogenetic Testing Market Forecast
10.4.3 UK Neurogenetic Testing Market Forecast
10.4.4 Italy Neurogenetic Testing Market Forecast
10.4.5 Russia Neurogenetic Testing Market Forecast
10.5 Middle East & Africa Neurogenetic Testing Forecast by Region (2025-2030)
10.5.1 Egypt Neurogenetic Testing Market Forecast
10.5.2 South Africa Neurogenetic Testing Market Forecast
10.5.3 Israel Neurogenetic Testing Market Forecast
10.5.4 Turkey Neurogenetic Testing Market Forecast
10.5.5 GCC Countries Neurogenetic Testing Market Forecast
10.6 Global Neurogenetic Testing Forecast by Type (2025-2030)
10.7 Global Neurogenetic Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Information
11.1.2 Quest Diagnostics Neurogenetic Testing Product Offered
11.1.3 Quest Diagnostics Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Quest Diagnostics Main Business Overview
11.1.5 Quest Diagnostics Latest Developments
11.2 Mayo Clinic
11.2.1 Mayo Clinic Company Information
11.2.2 Mayo Clinic Neurogenetic Testing Product Offered
11.2.3 Mayo Clinic Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mayo Clinic Main Business Overview
11.2.5 Mayo Clinic Latest Developments
11.3 GeneDx
11.3.1 GeneDx Company Information
11.3.2 GeneDx Neurogenetic Testing Product Offered
11.3.3 GeneDx Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GeneDx Main Business Overview
11.3.5 GeneDx Latest Developments
11.4 Illumina
11.4.1 Illumina Company Information
11.4.2 Illumina Neurogenetic Testing Product Offered
11.4.3 Illumina Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Illumina Main Business Overview
11.4.5 Illumina Latest Developments
11.5 Labcorp
11.5.1 Labcorp Company Information
11.5.2 Labcorp Neurogenetic Testing Product Offered
11.5.3 Labcorp Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Labcorp Main Business Overview
11.5.5 Labcorp Latest Developments
11.6 Invitae
11.6.1 Invitae Company Information
11.6.2 Invitae Neurogenetic Testing Product Offered
11.6.3 Invitae Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Invitae Main Business Overview
11.6.5 Invitae Latest Developments
11.7 MedGenome Labs
11.7.1 MedGenome Labs Company Information
11.7.2 MedGenome Labs Neurogenetic Testing Product Offered
11.7.3 MedGenome Labs Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MedGenome Labs Main Business Overview
11.7.5 MedGenome Labs Latest Developments
11.8 Connecticut Children’s
11.8.1 Connecticut Children’s Company Information
11.8.2 Connecticut Children’s Neurogenetic Testing Product Offered
11.8.3 Connecticut Children’s Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Connecticut Children’s Main Business Overview
11.8.5 Connecticut Children’s Latest Developments
11.9 CENTOGENE
11.9.1 CENTOGENE Company Information
11.9.2 CENTOGENE Neurogenetic Testing Product Offered
11.9.3 CENTOGENE Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CENTOGENE Main Business Overview
11.9.5 CENTOGENE Latest Developments
11.10 Victorian Clinical Genetics Services
11.10.1 Victorian Clinical Genetics Services Company Information
11.10.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Offered
11.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Victorian Clinical Genetics Services Main Business Overview
11.10.5 Victorian Clinical Genetics Services Latest Developments
11.11 PacBio
11.11.1 PacBio Company Information
11.11.2 PacBio Neurogenetic Testing Product Offered
11.11.3 PacBio Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 PacBio Main Business Overview
11.11.5 PacBio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurogenetic Testing Market Size 2019-2030
2.1.2 Neurogenetic Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurogenetic Testing Segment by Type
2.2.1 Exome Sequencing
2.2.2 Whole Genome Sequencing
2.2.3 RNA Sequencing
2.2.4 General DNA Testing
2.3 Neurogenetic Testing Market Size by Type
2.3.1 Neurogenetic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurogenetic Testing Market Size Market Share by Type (2019-2024)
2.4 Neurogenetic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Research Institutes
2.4.4 Diagnostics Laboratories
2.5 Neurogenetic Testing Market Size by Application
2.5.1 Neurogenetic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurogenetic Testing Market Size Market Share by Application (2019-2024)
3 NEUROGENETIC TESTING MARKET SIZE BY PLAYER
3.1 Neurogenetic Testing Market Size Market Share by Players
3.1.1 Global Neurogenetic Testing Revenue by Players (2019-2024)
3.1.2 Global Neurogenetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Neurogenetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROGENETIC TESTING BY REGIONS
4.1 Neurogenetic Testing Market Size by Regions (2019-2024)
4.2 Americas Neurogenetic Testing Market Size Growth (2019-2024)
4.3 APAC Neurogenetic Testing Market Size Growth (2019-2024)
4.4 Europe Neurogenetic Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurogenetic Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurogenetic Testing Market Size by Country (2019-2024)
5.2 Americas Neurogenetic Testing Market Size by Type (2019-2024)
5.3 Americas Neurogenetic Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurogenetic Testing Market Size by Region (2019-2024)
6.2 APAC Neurogenetic Testing Market Size by Type (2019-2024)
6.3 APAC Neurogenetic Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurogenetic Testing by Country (2019-2024)
7.2 Europe Neurogenetic Testing Market Size by Type (2019-2024)
7.3 Europe Neurogenetic Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurogenetic Testing by Region (2019-2024)
8.2 Middle East & Africa Neurogenetic Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurogenetic Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROGENETIC TESTING MARKET FORECAST
10.1 Global Neurogenetic Testing Forecast by Regions (2025-2030)
10.1.1 Global Neurogenetic Testing Forecast by Regions (2025-2030)
10.1.2 Americas Neurogenetic Testing Forecast
10.1.3 APAC Neurogenetic Testing Forecast
10.1.4 Europe Neurogenetic Testing Forecast
10.1.5 Middle East & Africa Neurogenetic Testing Forecast
10.2 Americas Neurogenetic Testing Forecast by Country (2025-2030)
10.2.1 United States Neurogenetic Testing Market Forecast
10.2.2 Canada Neurogenetic Testing Market Forecast
10.2.3 Mexico Neurogenetic Testing Market Forecast
10.2.4 Brazil Neurogenetic Testing Market Forecast
10.3 APAC Neurogenetic Testing Forecast by Region (2025-2030)
10.3.1 China Neurogenetic Testing Market Forecast
10.3.2 Japan Neurogenetic Testing Market Forecast
10.3.3 Korea Neurogenetic Testing Market Forecast
10.3.4 Southeast Asia Neurogenetic Testing Market Forecast
10.3.5 India Neurogenetic Testing Market Forecast
10.3.6 Australia Neurogenetic Testing Market Forecast
10.4 Europe Neurogenetic Testing Forecast by Country (2025-2030)
10.4.1 Germany Neurogenetic Testing Market Forecast
10.4.2 France Neurogenetic Testing Market Forecast
10.4.3 UK Neurogenetic Testing Market Forecast
10.4.4 Italy Neurogenetic Testing Market Forecast
10.4.5 Russia Neurogenetic Testing Market Forecast
10.5 Middle East & Africa Neurogenetic Testing Forecast by Region (2025-2030)
10.5.1 Egypt Neurogenetic Testing Market Forecast
10.5.2 South Africa Neurogenetic Testing Market Forecast
10.5.3 Israel Neurogenetic Testing Market Forecast
10.5.4 Turkey Neurogenetic Testing Market Forecast
10.5.5 GCC Countries Neurogenetic Testing Market Forecast
10.6 Global Neurogenetic Testing Forecast by Type (2025-2030)
10.7 Global Neurogenetic Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Information
11.1.2 Quest Diagnostics Neurogenetic Testing Product Offered
11.1.3 Quest Diagnostics Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Quest Diagnostics Main Business Overview
11.1.5 Quest Diagnostics Latest Developments
11.2 Mayo Clinic
11.2.1 Mayo Clinic Company Information
11.2.2 Mayo Clinic Neurogenetic Testing Product Offered
11.2.3 Mayo Clinic Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mayo Clinic Main Business Overview
11.2.5 Mayo Clinic Latest Developments
11.3 GeneDx
11.3.1 GeneDx Company Information
11.3.2 GeneDx Neurogenetic Testing Product Offered
11.3.3 GeneDx Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GeneDx Main Business Overview
11.3.5 GeneDx Latest Developments
11.4 Illumina
11.4.1 Illumina Company Information
11.4.2 Illumina Neurogenetic Testing Product Offered
11.4.3 Illumina Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Illumina Main Business Overview
11.4.5 Illumina Latest Developments
11.5 Labcorp
11.5.1 Labcorp Company Information
11.5.2 Labcorp Neurogenetic Testing Product Offered
11.5.3 Labcorp Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Labcorp Main Business Overview
11.5.5 Labcorp Latest Developments
11.6 Invitae
11.6.1 Invitae Company Information
11.6.2 Invitae Neurogenetic Testing Product Offered
11.6.3 Invitae Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Invitae Main Business Overview
11.6.5 Invitae Latest Developments
11.7 MedGenome Labs
11.7.1 MedGenome Labs Company Information
11.7.2 MedGenome Labs Neurogenetic Testing Product Offered
11.7.3 MedGenome Labs Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MedGenome Labs Main Business Overview
11.7.5 MedGenome Labs Latest Developments
11.8 Connecticut Children’s
11.8.1 Connecticut Children’s Company Information
11.8.2 Connecticut Children’s Neurogenetic Testing Product Offered
11.8.3 Connecticut Children’s Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Connecticut Children’s Main Business Overview
11.8.5 Connecticut Children’s Latest Developments
11.9 CENTOGENE
11.9.1 CENTOGENE Company Information
11.9.2 CENTOGENE Neurogenetic Testing Product Offered
11.9.3 CENTOGENE Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CENTOGENE Main Business Overview
11.9.5 CENTOGENE Latest Developments
11.10 Victorian Clinical Genetics Services
11.10.1 Victorian Clinical Genetics Services Company Information
11.10.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Offered
11.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Victorian Clinical Genetics Services Main Business Overview
11.10.5 Victorian Clinical Genetics Services Latest Developments
11.11 PacBio
11.11.1 PacBio Company Information
11.11.2 PacBio Neurogenetic Testing Product Offered
11.11.3 PacBio Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 PacBio Main Business Overview
11.11.5 PacBio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurogenetic Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Exome Sequencing
Table 3. Major Players of Whole Genome Sequencing
Table 4. Major Players of RNA Sequencing
Table 5. Major Players of General DNA Testing
Table 6. Neurogenetic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 9. Neurogenetic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 12. Global Neurogenetic Testing Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Neurogenetic Testing Revenue Market Share by Player (2019-2024)
Table 14. Neurogenetic Testing Key Players Head office and Products Offered
Table 15. Neurogenetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neurogenetic Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Neurogenetic Testing Market Size Market Share by Regions (2019-2024)
Table 20. Global Neurogenetic Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Neurogenetic Testing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Neurogenetic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Neurogenetic Testing Market Size Market Share by Country (2019-2024)
Table 24. Americas Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 26. Americas Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 28. APAC Neurogenetic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Table 30. APAC Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 32. APAC Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 34. Europe Neurogenetic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Neurogenetic Testing Market Size Market Share by Country (2019-2024)
Table 36. Europe Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 38. Europe Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Neurogenetic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Neurogenetic Testing
Table 47. Key Market Challenges & Risks of Neurogenetic Testing
Table 48. Key Industry Trends of Neurogenetic Testing
Table 49. Global Neurogenetic Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Neurogenetic Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Neurogenetic Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Neurogenetic Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Quest Diagnostics Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 54. Quest Diagnostics Neurogenetic Testing Product Offered
Table 55. Quest Diagnostics Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Quest Diagnostics Main Business
Table 57. Quest Diagnostics Latest Developments
Table 58. Mayo Clinic Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 59. Mayo Clinic Neurogenetic Testing Product Offered
Table 60. Mayo Clinic Main Business
Table 61. Mayo Clinic Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Mayo Clinic Latest Developments
Table 63. GeneDx Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 64. GeneDx Neurogenetic Testing Product Offered
Table 65. GeneDx Main Business
Table 66. GeneDx Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. GeneDx Latest Developments
Table 68. Illumina Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 69. Illumina Neurogenetic Testing Product Offered
Table 70. Illumina Main Business
Table 71. Illumina Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Illumina Latest Developments
Table 73. Labcorp Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 74. Labcorp Neurogenetic Testing Product Offered
Table 75. Labcorp Main Business
Table 76. Labcorp Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Labcorp Latest Developments
Table 78. Invitae Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 79. Invitae Neurogenetic Testing Product Offered
Table 80. Invitae Main Business
Table 81. Invitae Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Invitae Latest Developments
Table 83. MedGenome Labs Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 84. MedGenome Labs Neurogenetic Testing Product Offered
Table 85. MedGenome Labs Main Business
Table 86. MedGenome Labs Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. MedGenome Labs Latest Developments
Table 88. Connecticut Children’s Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 89. Connecticut Children’s Neurogenetic Testing Product Offered
Table 90. Connecticut Children’s Main Business
Table 91. Connecticut Children’s Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Connecticut Children’s Latest Developments
Table 93. CENTOGENE Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 94. CENTOGENE Neurogenetic Testing Product Offered
Table 95. CENTOGENE Main Business
Table 96. CENTOGENE Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. CENTOGENE Latest Developments
Table 98. Victorian Clinical Genetics Services Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 99. Victorian Clinical Genetics Services Neurogenetic Testing Product Offered
Table 100. Victorian Clinical Genetics Services Main Business
Table 101. Victorian Clinical Genetics Services Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Victorian Clinical Genetics Services Latest Developments
Table 103. PacBio Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 104. PacBio Neurogenetic Testing Product Offered
Table 105. PacBio Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. PacBio Main Business
Table 107. PacBio Latest Developments
Table 1. Neurogenetic Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Exome Sequencing
Table 3. Major Players of Whole Genome Sequencing
Table 4. Major Players of RNA Sequencing
Table 5. Major Players of General DNA Testing
Table 6. Neurogenetic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 9. Neurogenetic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 12. Global Neurogenetic Testing Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Neurogenetic Testing Revenue Market Share by Player (2019-2024)
Table 14. Neurogenetic Testing Key Players Head office and Products Offered
Table 15. Neurogenetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neurogenetic Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Neurogenetic Testing Market Size Market Share by Regions (2019-2024)
Table 20. Global Neurogenetic Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Neurogenetic Testing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Neurogenetic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Neurogenetic Testing Market Size Market Share by Country (2019-2024)
Table 24. Americas Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 26. Americas Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 28. APAC Neurogenetic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Table 30. APAC Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 32. APAC Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 34. Europe Neurogenetic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Neurogenetic Testing Market Size Market Share by Country (2019-2024)
Table 36. Europe Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 38. Europe Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Neurogenetic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Neurogenetic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Neurogenetic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Neurogenetic Testing
Table 47. Key Market Challenges & Risks of Neurogenetic Testing
Table 48. Key Industry Trends of Neurogenetic Testing
Table 49. Global Neurogenetic Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Neurogenetic Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Neurogenetic Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Neurogenetic Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Quest Diagnostics Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 54. Quest Diagnostics Neurogenetic Testing Product Offered
Table 55. Quest Diagnostics Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Quest Diagnostics Main Business
Table 57. Quest Diagnostics Latest Developments
Table 58. Mayo Clinic Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 59. Mayo Clinic Neurogenetic Testing Product Offered
Table 60. Mayo Clinic Main Business
Table 61. Mayo Clinic Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Mayo Clinic Latest Developments
Table 63. GeneDx Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 64. GeneDx Neurogenetic Testing Product Offered
Table 65. GeneDx Main Business
Table 66. GeneDx Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. GeneDx Latest Developments
Table 68. Illumina Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 69. Illumina Neurogenetic Testing Product Offered
Table 70. Illumina Main Business
Table 71. Illumina Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Illumina Latest Developments
Table 73. Labcorp Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 74. Labcorp Neurogenetic Testing Product Offered
Table 75. Labcorp Main Business
Table 76. Labcorp Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Labcorp Latest Developments
Table 78. Invitae Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 79. Invitae Neurogenetic Testing Product Offered
Table 80. Invitae Main Business
Table 81. Invitae Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Invitae Latest Developments
Table 83. MedGenome Labs Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 84. MedGenome Labs Neurogenetic Testing Product Offered
Table 85. MedGenome Labs Main Business
Table 86. MedGenome Labs Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. MedGenome Labs Latest Developments
Table 88. Connecticut Children’s Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 89. Connecticut Children’s Neurogenetic Testing Product Offered
Table 90. Connecticut Children’s Main Business
Table 91. Connecticut Children’s Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Connecticut Children’s Latest Developments
Table 93. CENTOGENE Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 94. CENTOGENE Neurogenetic Testing Product Offered
Table 95. CENTOGENE Main Business
Table 96. CENTOGENE Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. CENTOGENE Latest Developments
Table 98. Victorian Clinical Genetics Services Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 99. Victorian Clinical Genetics Services Neurogenetic Testing Product Offered
Table 100. Victorian Clinical Genetics Services Main Business
Table 101. Victorian Clinical Genetics Services Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Victorian Clinical Genetics Services Latest Developments
Table 103. PacBio Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 104. PacBio Neurogenetic Testing Product Offered
Table 105. PacBio Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. PacBio Main Business
Table 107. PacBio Latest Developments
LIST OF FIGURES
Figure 1. Neurogenetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurogenetic Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurogenetic Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurogenetic Testing Sales Market Share by Country/Region (2023)
Figure 8. Neurogenetic Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurogenetic Testing Market Size Market Share by Type in 2023
Figure 10. Neurogenetic Testing in Hospitals
Figure 11. Global Neurogenetic Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Neurogenetic Testing in Specialty Clinics
Figure 13. Global Neurogenetic Testing Market: Specialty Clinics (2019-2024) & ($ Millions)
Figure 14. Neurogenetic Testing in Research Institutes
Figure 15. Global Neurogenetic Testing Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Neurogenetic Testing in Diagnostics Laboratories
Figure 17. Global Neurogenetic Testing Market: Diagnostics Laboratories (2019-2024) & ($ Millions)
Figure 18. Global Neurogenetic Testing Market Size Market Share by Application in 2023
Figure 19. Global Neurogenetic Testing Revenue Market Share by Player in 2023
Figure 20. Global Neurogenetic Testing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 22. APAC Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 23. Europe Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 25. Americas Neurogenetic Testing Value Market Share by Country in 2023
Figure 26. United States Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Neurogenetic Testing Market Size Market Share by Region in 2023
Figure 31. APAC Neurogenetic Testing Market Size Market Share by Type in 2023
Figure 32. APAC Neurogenetic Testing Market Size Market Share by Application in 2023
Figure 33. China Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 40. Europe Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 56. APAC Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 57. Europe Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 59. United States Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 60. Canada Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 63. China Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 64. Japan Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 65. Korea Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 67. India Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 68. Australia Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 69. Germany Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 70. France Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 71. UK Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 72. Italy Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 73. Russia Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 74. Spain Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 77. Israel Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 80. Global Neurogenetic Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Neurogenetic Testing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neurogenetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurogenetic Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurogenetic Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurogenetic Testing Sales Market Share by Country/Region (2023)
Figure 8. Neurogenetic Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurogenetic Testing Market Size Market Share by Type in 2023
Figure 10. Neurogenetic Testing in Hospitals
Figure 11. Global Neurogenetic Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Neurogenetic Testing in Specialty Clinics
Figure 13. Global Neurogenetic Testing Market: Specialty Clinics (2019-2024) & ($ Millions)
Figure 14. Neurogenetic Testing in Research Institutes
Figure 15. Global Neurogenetic Testing Market: Research Institutes (2019-2024) & ($ Millions)
Figure 16. Neurogenetic Testing in Diagnostics Laboratories
Figure 17. Global Neurogenetic Testing Market: Diagnostics Laboratories (2019-2024) & ($ Millions)
Figure 18. Global Neurogenetic Testing Market Size Market Share by Application in 2023
Figure 19. Global Neurogenetic Testing Revenue Market Share by Player in 2023
Figure 20. Global Neurogenetic Testing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 22. APAC Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 23. Europe Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Neurogenetic Testing Market Size 2019-2024 ($ Millions)
Figure 25. Americas Neurogenetic Testing Value Market Share by Country in 2023
Figure 26. United States Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Neurogenetic Testing Market Size Market Share by Region in 2023
Figure 31. APAC Neurogenetic Testing Market Size Market Share by Type in 2023
Figure 32. APAC Neurogenetic Testing Market Size Market Share by Application in 2023
Figure 33. China Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Neurogenetic Testing Market Size Market Share by Country in 2023
Figure 40. Europe Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Neurogenetic Testing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Neurogenetic Testing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Neurogenetic Testing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Neurogenetic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 56. APAC Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 57. Europe Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 59. United States Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 60. Canada Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 63. China Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 64. Japan Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 65. Korea Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 67. India Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 68. Australia Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 69. Germany Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 70. France Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 71. UK Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 72. Italy Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 73. Russia Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 74. Spain Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 77. Israel Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Neurogenetic Testing Market Size 2025-2030 ($ Millions)
Figure 80. Global Neurogenetic Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Neurogenetic Testing Market Size Market Share Forecast by Application (2025-2030)
